A thorough risk evaluation with your doctor is essential before starting treatment
Honest tradeoff: most off-the-shelf telehealth platforms handle the easy 10% (video, scheduling, basic intake) and leave the hard 90% (compound Rx workflow, audit-grade documentation, multi-state licensure tracking, outcome capture for limited-evidence compounds) for the practice to figure out
Interestingly, oral semaglutide for weight loss in non-diabetics is also an approved use, which means you don't need a diabetes diagnosis to qualify for this treatment
1 With both treatments in our trial, as weight reduction increased, greater improvements occurred in cardiometabolic risk factors, including blood pressure, glycemia, and lipid levels, which is consistent with the findings in previous reports, the study authors said
Rocca AS & Brubaker PL (2001)
Both Tirzepatide and Semaglutide treatment can lead to significant weight loss